![](https://www.ncardia.com/hubfs/iStock-1328955974.jpg)
The Urgent Need for Reliable Cell Models in ALS Research
![](https://www.ncardia.com/hubfs/July%203_%20Social%20post@1x.png)
Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment
![](https://www.ncardia.com/hubfs/May%2012_%20social%20post@1x.png)
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models
![](https://www.ncardia.com/hubfs/September%2030_%20FDA%20modernization%20act.png)
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials
![](https://www.ncardia.com/hubfs/Blog%20Featured%20Images/Featured%20image_Press%20release%202%20Kiniciti.png)
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings
![](https://www.ncardia.com/hubfs/Blog%20Featured%20Images/Featured%20image_Press%20release%204%20Lung%20consortium.png)
Press release: improving the early detection, prevention and treatment of lung disease